Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03814824 · ClinicalTrials.gov registry record · NA
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT03814824: Completed NA study, sponsored by Northwell Health.
NCT03814824 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03814824, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
This is a prospective randomized clinical trial examining how IRIS (Intelligent Real-time Image Segmentation) affects biopsy patterns in VLE (Volumetric laser endomicroscopy).
Primary Outcome
The length of time required to fully assess and interpret the results of a VLE scan. Time will be a surrogate for ease of interpretation. Time will be recorded from start of image interpretation to the end of image interpretation. Length of the Barrett's segment will be taken into account (time per cm of Barrett's) when comparing this outcome between patients and procedures.
Interventions
- DIAGNOSTIC_TEST IRIS (Intelligent real-time image segmentation)
- DIAGNOSTIC_TEST VLE (Volumetric laser endomicroscopy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT03814824 record still lists
NCT03814824 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which IRIS (Intelligent real-time image segmentation) is the first listed.
NCT03814824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03814824 about?
NCT03814824 is a clinical study titled "Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)". This is a prospective randomized clinical trial examining how IRIS (Intelligent Real-time Image Segmentation) affects biopsy patterns in VLE (Volumetric laser endomicroscopy).
What is the current status of trial NCT03814824?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2019-01-23. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT03814824?
The interventions under investigation include: IRIS (Intelligent real-time image segmentation) (DIAGNOSTIC_TEST), VLE (Volumetric laser endomicroscopy) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03814824?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03814824's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI